This research demonstrates that lymphotoxin-driven myositis worsens in tandem with autophagy impairment in mice, highlighting disease complexity.
Key Points
Chronic myositis was induced in transgenic mice expressing lymphotoxin signaling, leading to significant muscle pathology.
The study confirmed that autophagy impairment, while separately inducing inflammation, exacerbated myositis pathology when combined.
Using a novel preclinical mouse model, researchers analyzed muscle tissue at multiple biological levels, including transcriptional and histological assessments.
These findings suggest that standard treatments may be ineffective for IBM-like symptoms, highlighting challenges in managing this muscular disorder.